Bustin, KA, Abbas, A, Abt, MC, Zackular, JP, Matthews, ML*. Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes. Front. Pharmacol. 2023. 14, 1074619.
Wang X, Lin Z, Bustin KA, McKnight NR, Parsons WH, Matthews ML*. Discovery of Potent and Selective Inhibitors against Protein-Derived Electrophilic Cofactors. J. Am. Chem. Soc. 2022. 144, 5377-5388.
Activity-Based Hydrazine Probes for Protein Profiling of Electrophilic Functionality in Therapeutic Targets. ACS Central Science Article ASAP. DOI: 10.1021/acscentsci.1c00616
Matthews ML. Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications. WO 20190204336A1 (2019)
Dettling SE, Ahmadi M, Lin Z, Matthews ML*. (2020). Discovery of electrophiles and profiling of enzyme cofactors. Curr. Protoc. Chem. Biol., 12, e86.
Lin Z, Wang X, Bustin KA, He L, Suciu RM, Schek N, Ahmadi M, Hu K, Olsen EJ, Parsons WH, Witze ES, Morton PD, Gregus AM, Buczynski MW, Matthews ML. Hydrazines as versatile chemical biology probes and drug-discovery tools for cofactor-dependent enzymes. bioRxiv (2020)
Pan J‡, Wenger ES‡, Matthews ML‡, Pollock CJ, Bhardwaj M, Kim AJ, Allen BD, Grossman RB, Krebs C, and Bollinger, Jr. JM. (‡equal contribution). Evidence for Modulation of Oxygen-Rebound Rate in Control of Outcome by Iron(II)- and 2-Oxogl.utarate-Dependent Oxygenases.. J. Am. Chem. Soc 141, 15153−15165 (2019)
EJ Blaesi, GP Palowitch, K Hu, AJ Kim, HR Rose, RB Alapati, MG Lougee, HJ Kim, KO Tan, AT Taguchi, TN Laremore, RG Griffin*, C Krebs*, ML Matthews*, A Silakov*, JM Bollinger, Jr.*, BD Allen*, AK Boal*. (*co-corresponding authors).. Metal-free class Ie ribonucleotide reductase from pathogens initiates catalysis with a tyrosine-derived dihydroxyphenylalanine radical. PNAS 115 (40), 10022-10027 (2018)
Martinie RJ, Pollock CJ, Matthews ML, Bollinger JM Jr, Krebs C, Silakov A. . Vanadyl as a Stable Structural Mimic of Reactive Ferryl Intermediates in Mononuclear Nonheme-Iron Enzymes.. Inorg. Chem. 56, 13382-13389 (2017)
Kornahrens, A, Cognetta, A Brody D, Matthews ML, Cravatt BF & Boger D.. Design of benzoxathiazin-3-one 1,1-dioxides as a new class of irreversible serine hydrolase inhibitors: discovery of a uniquely selective PNPLA4 inhibitor. J. Am. Chem. Soc. 139, 7052–7061 (2017)
